c-Myc-dependent etoposide-induced apoptosis involves activation of bax and caspases, and PKCdelta signaling

Journal of Cellular Biochemistry

Volumn 98, Issue 6, 2006, Pages 1597-1614

  Albihn, Ami ^a   Lovén, Jakob ^a   Ohlsson, Johan ^a   Osorio, Lyda M ^a   Henriksson, Marie ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Apoptosis; Bax; c Myc; Caspase; Cytotoxic drugs; Etoposide; PKC

Indexed keywords

CASPASE; CISPLATIN; CYTOTOXIC AGENT; DOXORUBICIN; ETOPOSIDE; MYC PROTEIN; PROTEIN BAX; PROTEIN KINASE C DELTA; STAUROSPORINE; TRANSCRIPTION FACTOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL DEATH; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; FIBROBLAST; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; MOUSE; NONHUMAN; NULL ALLELE; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; RAT; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CASPASES; CELL LINE; CISPLATIN; DOXORUBICIN; ETOPOSIDE; MICE; NIH 3T3 CELLS; NUCLEIC ACID SYNTHESIS INHIBITORS; PROTEIN KINASE C-DELTA; PROTO-ONCOGENE PROTEINS C-MYC; RATS; RECEPTORS, TUMOR NECROSIS FACTOR; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 33746479626     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.20816     Document Type: Article

References (60)

1. 2 phase of the cell cycle. Mol Cell Biol 21:4929-4937.
2. Bejarano MT, Albihn A, Cornvik T, Brijker SO, Asker C, Osorio LM, Henriksson M. 2000. Inhibition of cell growth and apoptosis by inducible expression of the transcriptional repressor Mad1. Exp Cell Res 260:61-72.
3. Belmokhtar CA, Hillion J, Ségal-Bendirdjian E. 2001. Staurosporine induces apoptosis through both caspase-dependent and caspase-independent mechanisms. Oncogene 20:3354-3362.
4. Blass M, Kronfeld I, Kazimirsky G, Blumberg PM, Brodie C. 2002. Tyrosine phosphorylation of protein kinase C δ is essential for its apoptotic effect in response to etoposide. Mol Cell Biol 22:182-195.
5. Brodie C, Blumberg PM. 2003. Regulation of cell apoptosis by protein kinase c delta. Apoptosis 8:19-27.
6. Brunelle JK, Santore MT, Budinger GR, Tang Y, Barrett TA, Zong WX, Kandel E, Keith B, Simon MC, Thompson CB, Hay N, Chandel NS. 2004. c-Myc sensitization to oxygen deprivation-induced cell death is dependent on Bax/Bak, but is independent of p53 and hypoxia-inducible factor-1. J Biol Chem 279:4305-4312.
7. Bush A, Mateyak M, Dugan K, Obaya A, Adachi S, Sedivy J, Cole M. 1998. c-myc null cells misregulate cad and gadd45 but not other proposed c-Myc targets. Genes Dev 12:3797-3802.
8. de Bruin EC, Meersma D, de Wilde J, den Otter I, Schipper EM, Medema JP, Peltenburg LTC. 2003. A serine protease is involved in the initiation of DNA damage-induced apoptosis. Cell Death Differ 10:1204-1212.
9. Desagher S, Osen-Sand A, Nichols A, Eskes R, Montessuit S, Lauper S, Maundrell K, Antonsson B, Martinou JC. 1999. Bid-induced conformational change of Bax is responsible for mitochondrial cytochrome-c release during apoptosis. J Cell Biol 144:891-910.
10. Desbiens KM, Deschesnes RG, Labrie MM, Devosses Y, Lambert H, Landry J, Bellmann K. 2003. c-Myc potentiates the mitochondrial pathway of apoptosis by acting upstream of apoptosis signal-regulating kinase 1 (Ask1) in the p38 signalling cascade. Biochem J 372:631-641.
11. Egger L, Schneider J, Rhême C, Tapernoux M, Häcki J, Borner C. 2003. Serine proteases mediate apoptosis-like cell death and phagocytosis under caspase-inhibiting conditions. Cell Death Differ 10:1188-1203.
12. Emoto Y, Manome Y, Meinhardt G, Kisaki H, Kharbanda S, Robertson M, Ghayur T, Wong WW, Kamen R, Weichselbaum R. 1995. Proteolytic activation of protein kinase C delta by an ICE-like protease in apoptotic cells. EMBO J 14:6148-6156.
13. Eskes R, Desagher S, Antonsson B, Martinou JC. 2000. Bid induces the oligomerization and insertion of Bax into the outer mitochondrial membrane. Mol Cell Biol 20:929-935.
14. Evan G, Littlewood T. 1998. A matter of life and cell death. Science 281:1317-1322.
15. Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, Waters CM, Penn LZ, Hancock DC. 1992. Induction of apoptosis in fibroblasts by c-myc protein. Cell 69:119-128.
16. Felsher DW, Bishop JM. 1999. Reversible tumorigenesis by MYC in hematopoietic lineages. Mol Cell 4:199-207.
17. Fulda S, Sieverts H, Friesen C, Herr I, Debatin KM. 1997. The CD95 (APO-1/Fas) system mediates drug-induced apoptosis in neuroblastoma cells. Cancer Res 57:3823-3829.
18. Gescher A. 2000. Staurosporine analogues-Pharmacological toys or useful antitumor agents? Crit Rev Oncol Hematol 34:127-135.
19. Gonzalez VM, Fuertes MA, Pérez-Alvarez MJ, Cervantes G, Moreno V, Alonso C, Pérez JM. 2000. Induction of apoptosis by the bis-Pt(III) complex [Pt(2)(2-mercaptopyrimidine)(4)Cl(2)]. Biochem Pharmacol 60:371-379.
20. Gorrini C, Donzelli M, Torriglia A, Supino R, Brison O, Bernardi R, Negri C, Denegri M, Counis MF, Ranzani GN, Scovassi AI. 2003. Effect of apoptogenic stimuli on colon carcinoma cell lines with a different c-myc expression level. Int J Mol Med 11:737-742.
21. Grassilli E, Ballabeni A, Maellaro E, Del Bello B, Helin K. 2004. Loss of Myc confers resistance to doxorubicin-induced apoptosis by preventing the activation of multiple serine protease- and caspase-mediated pathways. J Biol Chem 279:21318-21326.
22. Hande KR. 1998. Clinical applications of anticancer drugs targeted to topoisomerase II. Biochim Biophys Acta 1400:173-184.
23. Harrington EA, Bennett MR, Fanidi A, Evan GI. 1994. c-Myc-induced apoptosis in fibroblasts is inhibited by specific cytokines. EMBO J 13:3286-3295.
24. Henriksson M, Lüscher B. 1996. Proteins of the Myc network: Essential regulators of cell growth and differentiation. Adv Cancer Res 68:109-182.
25. Henriksson M, Selivanova G, Lindström M, Wiman KG. 2001. Inactivation of Myc-induced p53-dependent apoptosis in human tumors. Apoptosis 6:133-137.
26. Horiguchi-Yamada J, Fukumi S, Saito S, Nakayama R, Iwase S, Yamada H. 2002. DNA topoisomerase II inhibitor, Etoposide, induces p21WAF1/CIP1 through down-regulation of c-Myc in K562 cells. Anticancer Res 22:3827-3832.
27. Hotti A, Jarvinen K, Siivola P, Holtta E. 2000. Caspases and mitochondria in c-Myc-induced apoptosis: Identification of ATM as a new target of caspases. Oncogene 19:2354-2362.
28. Hueber AO, Evan GI. 1998. Traps to catch unwary oncogenes. Trends Genet 14:364-367.
29. Hueber AO, Zornig M, Lyon D, Suda T, Nagata S, Evan GI. 1997. Requirement for the CD95 receptor-ligand pathway in c-Myc-induced apoptosis. Science 278:1305-1309.
30. Iaccarino I, Hancock D, Evan G, Downward J. 2003. c-Myc induces cytochrome-c release in Rat1 fibroblasts by increasing outer mitochondrial membrane permeability in a Bid-dependent manner. Cell Death Differ 10:599-608.
31. Janicke RU, Sprengart ML, Wati MR, Porter AG. 1998. Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J Biol Chem 273:9357-9360.
32. Johansson AC, Steen H, Öllinger K, Roberg K. 2003. Cathepsin D mediates cytochrome-c release and caspase activation in human fibroblast apoptosis induced by staurosporine. Cell Death Differ 10:1253-1259.
33. Juin P, Hueber AO, Littlewood T, Evan G. 1999. c-Myc-induced sensitization to apoptosis is mediated through cytochrome-c release. Genes Dev 13:1367-1381.
34. Juin P, Hunt A, Littlewood T, Griffiths B, Swigart LB, Korsmeyer S, Evan G. 2002. c-Myc functionally cooperates with Bax to induce apoptosis. Mol Cell Biol 22:6158-6169.
35. Karpinich NO, Tafani M, Rothman RJ, Russo MA, Farber JL. 2002. The course of etoposide-induced apoptosis from damage to DNA and p53 activation to mitochondrial release of cytochrome-c. J Biol Chem 277:16547-16552.
36. Koriyama H, Kouchi Z, Umeda T, Saido TC, Momoi T, Ishiura S, Suzuki K. 1999. Proteolytic activation of protein kinase Cδ and ε by caspase-3 in U937 cells during chemotherapeutic agent-induced apoptosis. Cell Signal 11:831-838.
37. Lewis AE, Susarla R, Wong BCY, Langman MJS, Eggo MC. 2005. Protein kinase C delta is not activated by caspase-3 and its inhibition is sufficient to induce apoptosis in the colon cancer line, COLO 205. Cell Signal 17:253-262.
38. Ling M, Trollér U, Zeidman R, Lundberg C, Larsson C. 2004. Induction of neurites by the regulatory domains of PKCdelta and epsilon is counteracted by PKC catalytic activity and by the RhoA pathway. Exp Cell Res 292:135-150.
39. Maclean KH, Keller UB, Rodriguez-Galindo C, Nilsson JA, Cleveland JL. 2003. c-Myc augments gamma irradiation-induced apoptosis by suppressing Bcl-XL. Mol Cell Biol 23:7256-7270.
40. Mandic A, Viktorsson K, Molin M, Akusjärvi G, Eguchi H, Hayashi SI, Toi M, Hansson J, Linder S, Shoshan MC. 2001. Cisplatin induces the proapoptotic conformation of Bak in a ΔMEKK1-dependent manner. Mol Cell Biol 21:3684-3691.
41. Marhin WW, Chen S, Facchini LM, Fornace AJ, Jr., Penn LZ. 1997. Myc represses the growth arrest gene gadd45. Oncogene 14:2825-2834.
42. Mateyak MK, Obaya AJ, Adachi S, Sedivy JM. 1997. Phenotypes of c-Myc-deficient rat fibroblasts isolated by targeted homologous recombination. Cell Growth Differ 8:1039-1048.
43. McCurrach ME, Connor TMF, Knudson CM, Korsmeyer SJ, Lowe SW. 1997. Bax-deficiency promotes drug resistance and oncogenic transformation by attenuating p53-dependent apoptosis. Proc Natl Acad Sci USA 94:2345-2349.
44. Mitchell KO, Ricci MS, Miyashita T, Dicker DT, Jin Z, Reed JC, El-Deiry WS. 2000. Bax is a transcriptional target and mediator of c-Myc-induced apoptosis. Cancer Res 60:6318-6325.
45. Orlowski RZ, Eswara JR, Lafond-Walker A, Grever MR, Orlowski M, Dang CV. 1998. Tumor growth inhibition induced in a murine model of human Burkitt's lymphoma by a proteasome inhibitor. Cancer Res 58:4342-4348.
46. Panaretakis T, Pokrovskaja K, Shoshan MC, Grander D. 2002. Activation of Bak, Bax, and BH3-only proteins in the apoptotic response to doxorubicin. J Biol Chem 277:44317-44326.
47. Pelengaris S, Khan M, Evan G. 2002. c-MYC: More than just a matter of life and death. Nat Rev Cancer 2:764-776.
48. Peltenburg LT, de Bruin EC, Meersma D, Wilting S, Jurgensmeier JM, Schrier PI. 2004. c-Myc is able to sensitize human melanoma cells to diverse apoptotic triggers. Melanoma Res 14:3-12.
49. Pérez RP. 1998. Cellular and molecular determinants of cisplatin resistance. Eur J Cancer 34:1535-1542.
50. Pestell KE, Hobbs SM, Titley JC, Kelland LR, Walton MI. 2000. Effects of p53 status on sensitivity to platinum complexes in a human ovarian cancer cell line. Mol Pharmacol 57:503-511.
51. Prendergast GC. 1999. Mechanisms of apoptosis by c-Myc. Oncogene 18:2967-2987.
52. Rebbaa A, Chou PM, Emran M, Mirkin BL. 2001. Doxorubicin-induced apoptosis in caspase-8-deficient neuroblastoma cells is mediated through direct action on mitochondria. Cancer Chemother Pharmacol 48:423-428.
53. Smith JB, Wickstrom E. 1998. Antisense c-myc and immunostimulatory oligonucleotide inhibition of tumorigenesis in a murine B-cell lymphoma transplant model. J Natl Cancer Inst 90:1146-1154.
54. Soucie EL, Annis MG, Sedivy J, Filmus J, Leber B, Andrews DW, Penn LZ. 2001. Myc potentiates apoptosis by stimulating Bax activity at the mitochondria. Mol Cell Biol 21:4725-4736.
55. Suzuki E, Handa K, Toledo MS, Hakomori S. 2004. Sphingosine-dependent apoptosis: A unified concept based on multiple mechanisms operating in concert. Proc Natl Acad Sci USA 101:14788-14793.
56. Tafani M, Karpinich NO, Hurster KA, Pastorino JG, Schneider T, Russo MA, Farber JL. 2002. Cytochrome-c release upon Fas receptor activation depends on translocation of full-length Bid and the induction of the mitochondrial permeability transition. J Biol Chem 277:10073-10082.
57. Teitz T, Wei T, Valentine MB, Vanin EF, Grenet J, Valentine VA, Behm FG, Look AT, Lahti JM, Kidd VJ. 2000. Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN. Nat Med 6:529-535.
58. Vivanco I, Sawyers CL. 2002. The phosphatidylinositol 3-kinase-Akt pathway in human cancer. Nat Rev Cancer 2:489-501.
59. Zeidman R, Löfgren B, Påhlman S, Larsson C. 1999. PKCepsilon, via its regulatory domain and independently of its catalytic domain, induces neurite-like processes in neuroblastoma cells. J Cell Biol 145:713-726.
60. Zha J, Harada H, Yang E, Jockel J, Korsmeyer SJ. 1996. Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L). Cell 87:619-628.